Yanazume, S.;                     Fang, J.;                     Islam, R.;                     Gao, S.;                     Kobayashi, H.    
        Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies. J. Pers. Med. 2022, 12, 814.
    https://doi.org/10.3390/jpm12050814
    AMA Style
    
                                Yanazume S,                                 Fang J,                                 Islam R,                                 Gao S,                                 Kobayashi H.        
                Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies. Journal of Personalized Medicine. 2022; 12(5):814.
        https://doi.org/10.3390/jpm12050814
    
    Chicago/Turabian Style
    
                                Yanazume, Shintaro,                                 Jun Fang,                                 Rayhanul Islam,                                 Shanghui Gao,                                 and Hiroaki Kobayashi.        
                2022. "Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies" Journal of Personalized Medicine 12, no. 5: 814.
        https://doi.org/10.3390/jpm12050814
    
    APA Style
    
                                Yanazume, S.,                                 Fang, J.,                                 Islam, R.,                                 Gao, S.,                                 & Kobayashi, H.        
        
        (2022). Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies. Journal of Personalized Medicine, 12(5), 814.
        https://doi.org/10.3390/jpm12050814